Tian Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tian Xu has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Jared Otto Kafader
Northwestern University
2 shared publications - Neil L. Kelleher
Northwestern University
2 shared publications - Amanda B. Hummon
Department of Chemistry and Biochemistry The Ohio State University Columbus Ohio USA
1 shared publication - Benjamin James Des Soye
Northwestern University
1 shared publication - Che-Fan Huang
Departments of Chemistry Molecular Biosciences, and Proteomics Center of Excellence Northwestern University 2170 Campus Dr. Silverman B550 Evanston Illinois 60208 USA
1 shared publication Chelsea Lock
Department of Chemistry and Molecular Biosciences, Chemistry of Life Processes Institute, Proteomics Center Excellence, Northwestern University, Evanston, IL, USA
1 shared publication
Latest Publications
- Open Access
- 10 April 2026
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 25 (5) , 101566
Probing Proteoform Heterogeneity From Single Human Oocytes
- 10 April 2026
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 25 (5) , 101566
Open AccessProbing Proteoform Heterogeneity From Single Human Oocytes
- 21 May 2025
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 24 (6) , 2916-2925
The Proteoform Landscape of Tau from the Human Brain
Tau is a microtubule-associated protein (MAP) and is critical for maintaining the cytoskeleton of neurons. Tau and its post-translational modifications (PTMs) have been studied for decades, yet the exact composition of intact tau and its truncation products present in the human brain has evaded study at the proteoform level. Here, we show that tau proteoform profiling and exact characterization are possible using immunoprecipitation (IP) and the new approach of individual ion mass spectrometry (I2MS). We provide a first glimpse of the tau proteoform landscape present in the CHAPS-soluble extracts from the temporal cortex of a control subject and a donor with Alzheimer's disease (AD). Profiling and identification of four isoforms (0N3R, 1N3R, 0N4R, and 1N4R), truncated products (e.g., 72-172 derived from the 0N3R/0N4R isoforms), and intact tau proteoforms harboring PTMs include phosphorylation, methylation, and acetylation. The specific tau proteoform identification typically employs proton transfer charge reduction (PTCR) and electron transfer dissociation (ETD) with spectral readout by individual ion tandem mass spectrometry (I2MS2). A precise understanding of the tau proteoform landscape over the course of neurodegeneration is critical to understand AD pathology vs related dementias. The assay approach reported here will advance AD research, gives a sense of what is technologically possible for new biomarker discovery and will assist the development of therapeutics using the most exact kind of compositional information on tau.
- 21 May 2025
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 24 (6) , 2916-2925
The Proteoform Landscape of Tau from the Human Brain
Tau is a microtubule-associated protein (MAP) and is critical for maintaining the cytoskeleton of neurons. Tau and its post-translational modifications (PTMs) have been studied for decades, yet the exact composition of intact tau and its truncation products present in the human brain has evaded study at the proteoform level. Here, we show that tau proteoform profiling and exact characterization are possible using immunoprecipitation (IP) and the new approach of individual ion mass spectrometry (I2MS). We provide a first glimpse of the tau proteoform landscape present in the CHAPS-soluble extracts from the temporal cortex of a control subject and a donor with Alzheimer's disease (AD). Profiling and identification of four isoforms (0N3R, 1N3R, 0N4R, and 1N4R), truncated products (e.g., 72-172 derived from the 0N3R/0N4R isoforms), and intact tau proteoforms harboring PTMs include phosphorylation, methylation, and acetylation. The specific tau proteoform identification typically employs proton transfer charge reduction (PTCR) and electron transfer dissociation (ETD) with spectral readout by individual ion tandem mass spectrometry (I2MS2). A precise understanding of the tau proteoform landscape over the course of neurodegeneration is critical to understand AD pathology vs related dementias. The assay approach reported here will advance AD research, gives a sense of what is technologically possible for new biomarker discovery and will assist the development of therapeutics using the most exact kind of compositional information on tau.
- Open Access
- 23 December 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (51)
Deep top-down proteomics revealed significant proteoform-level differences between metastatic and nonmetastatic colorectal cancer cells
Understanding cancer metastasis at the proteoform level is crucial for discovering previously unknown protein biomarkers for cancer diagnosis and drug development. We present the first top-down proteomics (TDP) study of a pair of isogenic human nonmetastatic and metastatic colorectal cancer (CRC) cell lines (SW480 and SW620). We identified 23,622 proteoforms of 2332 proteins from the two cell lines, representing nearly fivefold improvement in the number of proteoform identifications (IDs) compared to previous TDP datasets of human cancer cells. We revealed substantial differences between the SW480 and SW620 cell lines regarding proteoform and single amino acid variant (SAAV) profiles. Quantitative TDP unveiled differentially expressed proteoforms between the two cell lines, and the corresponding genes had diversified functions and were closely related to cancer. Our study represents a pivotal advance in TDP toward the characterization of human proteome in a proteoform-specific manner, which will transform basic and translational biomedical research.
- 23 December 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (51)
Open AccessDeep top-down proteomics revealed significant proteoform-level differences between metastatic and nonmetastatic colorectal cancer cells
Understanding cancer metastasis at the proteoform level is crucial for discovering previously unknown protein biomarkers for cancer diagnosis and drug development. We present the first top-down proteomics (TDP) study of a pair of isogenic human nonmetastatic and metastatic colorectal cancer (CRC) cell lines (SW480 and SW620). We identified 23,622 proteoforms of 2332 proteins from the two cell lines, representing nearly fivefold improvement in the number of proteoform identifications (IDs) compared to previous TDP datasets of human cancer cells. We revealed substantial differences between the SW480 and SW620 cell lines regarding proteoform and single amino acid variant (SAAV) profiles. Quantitative TDP unveiled differentially expressed proteoforms between the two cell lines, and the corresponding genes had diversified functions and were closely related to cancer. Our study represents a pivotal advance in TDP toward the characterization of human proteome in a proteoform-specific manner, which will transform basic and translational biomedical research.
- Open Access
A variational analysis of the spinorial Yamabe equation on product manifolds
This work is devoted to the analysis of the Yamabe problem on Spin manifolds and some applications to CMC immersions. Despite the efforts of many authors, very little is known on the existence of Yamabe metrics on general Spin manifolds. Motivated to bubbling phenomena for the Riemannian problem and recent multiplicity results in this setting, we investigate special spinorial Yamabe metrics on product manifolds developing a bubbling analysis which has independent interest in the present setting.
Open AccessA variational analysis of the spinorial Yamabe equation on product manifolds
This work is devoted to the analysis of the Yamabe problem on Spin manifolds and some applications to CMC immersions. Despite the efforts of many authors, very little is known on the existence of Yamabe metrics on general Spin manifolds. Motivated to bubbling phenomena for the Riemannian problem and recent multiplicity results in this setting, we investigate special spinorial Yamabe metrics on product manifolds developing a bubbling analysis which has independent interest in the present setting.